Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Kanghui to be Acquired by Medtronic in $816 Million Deal

publication date: Sep 28, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Kanghui Holdings, the Changzhou medical device maker, announced it will be acquired Medtronic for $816 million or $30.75 per ADS. The transaction increases Medtronic's presence in China for its large portfolio of medical devices, which includes everything from pacemakers and stents to spinal implants and surgical instruments. Founded in 1997, Kanghui staged its New York Stock Exchange IPO in August 2010 at a price of $10.25. More details....

Stock Symbols: (NYSE: KH) (NYSE: MDT)

Share this with colleagues:  




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors